PROCAPS GROUP SA (PROC)
LU2376511205 - Common Stock
PROCAPS GROUP SA
NASDAQ:PROC (12/20/2024, 8:00:00 PM)
After market: 2.5999 +0.09 (+3.58%)2.51
+0.07 (+2.87%)
Company Profile
Procaps Group SA is an international healthcare and pharmaceutical company. The firm develops, manufactures and sells prescription drugs and products that are differentiated by their combinations and pharmaceutical forms, as well as nutritional supplements which include omega 3 fish oils and high-potency clinical compounds. The company operates its business through 5 units which are Diabetrics, Farma Procaps, Softi Gel, Vital Care, and Clinical Specialties. Diabetrics provides diabetes solutions. Farma procaps formulates, manufactures and markets branded prescription drugs in Latin America. Softi Gel provides contract drug development and manufacturing services to third party pharmaceutical companies. Vital Care develops, manufactures and markets consumer healthcare products. Clinical Specialties develops, manufactures and markets complex drugs.
Company Info
PROCAPS GROUP SA
9, rue de Bitbourg
Luxembourg
CEO: Kyle P. Bransfield
Employees: 5500
Website: https://www.procapsgroup.com/
PROC News
17 hours ago - Procaps Group, S.A.Procaps Group Announces Key Shareholder and Board Decisions, Committee Restructuring, and Leadership Updates17 hours ago - Procaps Group, S.A.Procaps Group Announces Key Shareholder and Board Decisions, Committee Restructuring, and Leadership UpdatesMIAMI and BARRANQUILLA, Colombia, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated...
18 days ago - Procaps Group, S.A.Procaps Group Announces Financing, Shareholders Agreement and Board Updates18 days ago - Procaps Group, S.A.Procaps Group Announces Financing, Shareholders Agreement and Board UpdatesMIAMI and BARRANQUILLA, Colombia , Dec. 03, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading...
a month ago - Procaps Group, S.A.Procaps Receives Nasdaq Listing Determination; To Request Hearing and Further Stay Pending Hearinga month ago - Procaps Group, S.A.Procaps Receives Nasdaq Listing Determination; To Request Hearing and Further Stay Pending HearingMIAMI and BARRANQUILLA, Colombia, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), announced today...
PROC Twits
Here you can normally see the latest stock twits on PROC, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
